Ethnobotanical Perspectives on Herbal Medicines for Respiratory Diseases

Respiratory diseases rank high among international health concerns, causing a great abundance of asthma, bronchitis, influenza, and pneumonia, contributing significantly to disease, disability and death. In various settings, conventional therapy is effectively linked to side effects, cost and limited availability. This initiative increases attention toward ethnobotanical knowledge to prevent and manage respiratory disorders where local populations rely on medicinal plants. Ethnobotanical investigation emphasizes medicinal plants such as Inula helenium, Rosmarinus officinalis, Zingiber officinale and Ocimum sanctum, which contain active ingredients with bronchodilator, expectorant, anti-inflammatory, antimicrobial, antioxidant, and immunomodulatory properties. To improve respiratory function, these phytoconstituents exert their effects via various mechanisms, including the regulation of inflammatory cytokines, inhibition of bacterial growth, and reduction of oxidative stress. Traditional application evaluation has increased with modern pharmacological research, highlighting the therapeutic significance of plant-based medicine in respiratory healthcare. Moreover, the safety and toxicity of several therapeutic plants are among the most concerning issues, as such plants could be capable of causing poisonous, allergic, and/or drug-interaction reactions. To support this, the World Health Organization (WHO) has released guidelines, a focus on good agronomic and collecting practices (GACP), standardization, quality assurance, and post-marketing surveillance. In addition, the WHO also emphasizes the importance of traditional medicine in the modern health care system, especially in low-income areas with high prevalence of respiratory disease. In conclusion, traditional knowledge linked with modern scientific research may ultimately increase treatment results and increase therapeutic options for respiratory health care.